Loading...
Recent Advances in the Clinical Development of Immune Checkpoint Blockade Therapy for Mismatch Repair Proficient (pMMR)/non-MSI-H Metastatic Colorectal Cancer
Metastatic colorectal cancer (mCRC) continues to be associated with a poor prognosis, and there remains a significant unmet need for novel agents and treatment regimens. Major breakthroughs have been made with immune checkpoint blockade therapy in several disease types, including DNA mismatch repair...
Na minha lista:
| Udgivet i: | Clin Colorectal Cancer |
|---|---|
| Main Authors: | , |
| Format: | Artigo |
| Sprog: | Inglês |
| Udgivet: |
2018
|
| Fag: | |
| Online adgang: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6612427/ https://ncbi.nlm.nih.gov/pubmed/30072278 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.clcc.2018.06.004 |
| Tags: |
Tilføj Tag
Ingen Tags, Vær først til at tagge denne postø!
|